Discovery-stage antibody agonist platform targeting memory T cells to put the brakes on autoimmune overactivation. The approach leverages learnings from tumor immune evasion biology to restore immune balance in autoimmune diseases.
Status: Stealth
Location: Belgium
Related news
No related news at the moment